What's happening
This bill creates a fund and allows voluntary taxpayer contributions to support leukemia, lymphoma, and myeloma research, education, and treatment in New York.
Why it matters
Creates a dedicated state fund. specifically for leukemia, lymphoma, and myeloma research, education, and treatment, ensuring that voluntary taxpayer donations and other contributions are kept separate from the general budget and targeted directly to these causes.
Establishes a transparent reporting system. The Department of Health must submit an annual report detailing how the fund’s money was used, including information on grant recipients, award amounts, uses of the funds, and a financial summary, promoting public accountability.
Enables taxpayer participation. Both individuals and corporations can voluntarily contribute any whole dollar amount through their state tax returns, allowing residents to directly support cancer-related initiatives without affecting their tax liability.
Funds can support a broad range of organizations. Grants from the fund can go to public and private hospitals, medical centers, schools, and other groups, potentially expanding the reach and impact of funded research, education, and treatment programs across New York.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Fund Blood Cancer Research
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Recommit, enacting clause stricken
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Fund Blood Cancer Research
In Senate Committee · Health · Sponsor Michael Cusick
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
8742
IN SENATE
May 10, 2018
Introduced by Sen. SEPULVEDA -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, the tax law and the state finance law, in relation to providing for taxpayer gifts for leukemia, lymphoma and myeloma research, education and treatment and establishing the leukemia, lymphoma and myeloma research, education and treatment fund
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new article 27-CCC to read as follows:
ARTICLE 27-CCC LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM Section 2747. Leukemia, lymphoma and myeloma research, education and
treatment.
§ 2747. Leukemia, lymphoma and myeloma research, education and treatment. The commissioner shall establish within the department a program to promote research, education and treatment regarding leukemia, lymphoma and myeloma. To carry out the purposes of this section, the commissioner shall have the following powers and duties:
1. to promote research, education and treatment programs designed to reduce or prevent the incidence and severity of leukemia, lymphoma and myeloma;
2. to accept and expend any grants, awards or other funds or appropriations as may be available for these purposes subject to limitations as to the approval of expenditures and audit as prescribed for state funds by the state finance law; and
3. to enter into contracts within the amounts available therefor as may be necessary to implement the provisions of this section.
§ 2. The tax law is amended by adding a new section 209-L to read as follows:
§ 209-L. Gift for leukemia, lymphoma and myeloma research, education and treatment. Effective for any tax year commencing on or after January first, two thousand nineteen, a taxpayer in any taxable year may elect to contribute to the support of the leukemia, lymphoma and myeloma
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00255-06-8
S. 8742 2
research, education and treatment fund. Such contribution shall be in any whole dollar amount and shall not reduce the amount of the state tax owed by such taxpayer. The commissioner shall include space on the corporate income tax return to enable a taxpayer to make such contribution. Notwithstanding any other provision of law, all revenues collected pursuant to this section shall be credited to the leukemia, lymphoma and myeloma research, education and treatment fund and shall be used only for those purposes enumerated in section ninety-seven-rrrr of the state finance law.
§ 3. The tax law is amended by adding a new section 630-f to read as follows:
§ 630-f. Gift for leukemia, lymphoma and myeloma research, education and treatment. Effective for any tax year commencing on or after January first, two thousand nineteen, an individual in any taxable year may elect to contribute to the leukemia, lymphoma and myeloma research, education and treatment fund. Such contribution shall be in any whole dollar amount and shall not reduce the amount of state tax owed by such individual. The commissioner shall include space on the personal income tax return to enable a taxpayer to make such contribution. Notwithstanding any other provision of law all revenues collected pursuant to this section shall be credited to the leukemia, lymphoma and myeloma research, education and treatment fund and used only for those purposes enumerated in section ninety-seven-rrrr of the state finance law.
§ 4. The state finance law is amended by adding a new section 97-rrrr to read as follows:
§ 97-rrrr. Leukemia, lymphoma and myeloma research, education and treatment fund. 1. There is hereby established in the joint custody of the commissioner of taxation and finance and the comptroller, a special fund to be known as the "leukemia, lymphoma and myeloma research, education and treatment fund".
2. Such fund shall consist of all revenues received by the department of taxation and finance, pursuant to the provisions of section two hundred nine-L and section six hundred thirty-f of the tax law and all other moneys appropriated, credited, or transferred thereto from any other fund or source pursuant to law. Nothing contained in this section shall prevent the state from receiving grants, gifts or bequests for the purposes of the fund as defined in this section and depositing them into the fund according to law.
2-a. On or before the first day of February each year, the commissioner of health shall provide a written report to the temporary president of the senate, the speaker of the assembly, the chair of the senate finance committee, the chair of the assembly ways and means committee, the chair of the senate committee on health, the chair of the assembly health committee, the state comptroller and the public. Such report shall include how the monies of the fund were utilized during the preceding calendar year, and shall include:
(i) the amount of money dispersed from the fund and the award process used for such disbursements;
(ii) recipients of awards from the fund;
(iii) the amount awarded to each recipient;
(iv) the purposes for which such awards were granted; and
(v) a summary financial plan for such monies which shall include estimates of all receipts and all disbursements for the current and succeeding fiscal years, along with the actual results from the prior fiscal year.
S. 8742 3
3. Monies of the fund shall be expended only for leukemia, lymphoma and myeloma research, education and treatment projects. As used in this section, "leukemia, lymphoma and myeloma research, education and treatment projects" means research, education and treatment projects, including grants for leukemia, lymphoma and myeloma research, education and treatment, which, pursuant to section twenty-seven hundred forty-seven of the public health law, are approved by the department of health. Such grants may include, among others, grants to public and private hospitals, medical centers, medical schools and other organizations.
4. Monies shall be payable from the fund on the audit and warrant of the comptroller on vouchers approved and certified by the commissioner of health.
5. To the extent practicable, the commissioner of health shall ensure that all monies received during a fiscal year are expended prior to the end of that fiscal year.
§ 5. This act shall take effect immediately and shall apply to taxable years commencing on or after January 1, 2019.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, the tax law and the state finance law, in relation to providing for taxpayer gifts for leukemia, lymphoma and myeloma research, education and treatment and establishing the leukemia, lymphoma and myeloma research, education and treatment fund
Purpose or general idea of bill
The purpose of this bill is to provide easy access to help fund and support Leukemia, Lymphoma, and Myeloma research, education and treat- ment.
Summary of provisions
Section 1 - Amends the public health law by adding a new article 27-CCC. The new article provides the Commissioner of Health with the powers to: develop programs concerning Leukemia, Lymphoma, and Myeloma, to accept and expend grants, awards and other funding, and to enter into contracts necessary for program development and granting.
Read the full memo (823 words)
Section 2 - Amends the law by adding a new section 209-L. The new section provides for the Commissioner of Taxation and Finance to include a space on the corporate income tax return for contributions to Leuke- mia, Lymphoma, and Myeloma research, education and treatment.
Section 3 - Amends part 2 of article 22 of the tax law by adding new section 630-f. The new section provides for the Commissioner of Taxation and Finance to include a space on the individual income tax return for contributions to Leukemia, Lymphoma, and Myeloma research, education and treatment.
Section 4 - Amends the state finance law by adding a new section 97-rrrr. The new section provides for the establishment of a special fund, consisting of revenues received under section 209-L and 630-f of the tax law and any other moneys appropriated, credited or transferred, for Leukemia, Lymphoma and Myeloma research, education and treatment.
The custody of this fund will be held jointly by the Commissioner of Taxation and Finance and the Comptroller. The Commissioner of Health shall provide a written report on or before the first day of February each year to the Senate, Assembly, Senate Finance Committee, Assembly Ways and Means Committee, the Senate and Assembly Health Committee's, the State Comptroller and the public. Further, the new section provides that all monies in the fund to be used only for Leukemia, Lymphoma and Myeloma research, education and treatment programs approved by the Department of Health. Additionally, the new section provides that the Comptroller must approve releases of money that are certified by the Commissioner of Health and that all money in the fund should be used prior to the end of the fiscal year.
Section 5 - The effective date.
Justification
Research and treatment efforts for many diseases, including Alzheimer's and breast cancer, have benefited from additional funding resulting from having a "check-off box" placed on the individual and corporate income tax returns. Leukemia, Lymphoma and Myeloma are blood cancers originat- ing in the bone marrow and correlate with each other because of the unrestrained growth of the cells and the parallel functions which they possess. Leukemia, although more common in adults over the age of 64, is still the leading cause of disease death of children under 15 yrs old, with Acute Lymphocytic Leukemia (ALL) being the most common form of Leukemia in children. Treatment advances for Leukemia have proven to be prevalent in the survival rate over the years, with the survival rate increasing from 4% in 1960 to 85% in 1999. Lymphoma involves two partic- ular forms including Non-Hodgkin, which is the fifth most common cancer in the U.S. and Hodgkin Lymphoma, which mostly affects adolescents and young adults. Myeloma occurs mostly in people over 60 yrs old with males having a 50% higher chance than females of being diagnosed. Each year an estimated 106,200.people in the United States are diagnosed with Leukemia, Lymphoma, or Myeloma. At the present time, an estimated 670,950 Americans have blood cancers. Approximately 57,500 Americans will die from these hematological malignancies this year. In New York State alone, there are approximately 6,600 people diagnosed with a blood cancer each year and 3,500 people will succumb to this disease.
PRIOR LEGISLATIVE. HISTORY:
2017: A.1354-A Passed Assembly S.970-A Died in Senate Health 2016: A.49-A Passed Assembly S.1657-A Died in Senate Health 2015: A.49 Passed Assembly S.1657 Died in Senate Finance 2014: A.558-A Passed Assembly S.1967-A Died in Senate Health 2013: A.558-A Passed Assembly S.1976-A Died in Senate Health 2012: A.0283 Passed Assembly S.0569-Died in Senate Health 2011: A.0283 Passed Assembly S.0569-Died in Senate Health 2010: A.3075-A Died on 3rd Rdg. S.1197-A Died in Senate Health 2009: A.3075 Passed Assembly; 2008: A.1558-C Passed Assembly; S.3097-B Died in Senate Health 2007: A.1558-A Passed Assembly; S.3097-A Died in Senate Health 2006: A.3338-A Passed Assembly; S.2871-A Died in Senate Health; 2005: A.3338 Passed Assembly; S-2878-A Died in Senate Health 2004: A.9816 Passed Assembly; S.6491 Died in Senate Health
Fiscal implications for state and local governments
Minimal to the state.
Effective date
This act shall apply to taxable years commencing on or after January 1, 2019.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.